Video

Dr. Brannigan on genetic evaluation of the infertile male

Author(s):

Urology Times staff
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Robert E. Brannigan, MD, vice chair of Clinical Urology, Northwestern University, discusses which men with infertility issues should receive genetic testing.

      Related Videos
      Perry Xu, MD, answers a question during a Zoom video interview
      Perry Xu, MD, on the potential of AI in the endourology space
      Amy E. Krambeck, MD, answers a question during a Zoom video interview
      Amy E. Krambeck, MD, on what’s needed to improve safety, efficacy of HoLEP
      Illustration of prostate | Image Credit: © Judith - stock.adobe.com
      The role of preoperative imaging with HoLEP for BPH
      Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
      Incorporating emerging technologies into HoLEP for BPH
      Amy E. Krambeck, MD, answers a question during a Zoom video interview
      Amy E. Krambeck, MD, on patient selection for HoLEP
      Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
      An expert on why HoLEP is a “platinum standard” procedure
      Amy E. Krambeck, MD, answers a question during a Zoom video interview
      Amy E. Krambeck, MD, reflects on 754 HoLEP procedures performed by her team in 2024
      Paul Sieber, MD, on the future of genetic testing in prostate cancer
      Paul Sieber, MD, on the future of genetic testing in prostate cancer
      Prostate cancer cells | Image Credit: © Dr_Microbe - stock.adobe.com
      Expert: PSMA-PET should be considered at lower PSA levels
      Daniel Kwon, MD, answers a question during a Zoom video interview
      Daniel Kwon, MD, discusses study’s impact on veteran access to germline testing for prostate cancer
      Related Content
      Myriad Genetics, PATHOMIQ enter agreement for usage of AI platform for prostate cancer
      February 25th 2025

      Myriad Genetics, PATHOMIQ enter agreement for usage of AI platform for prostate cancer

      Hannah Clarke
      Myriad is planning to launch its first AI-driven prostate cancer clinical test later this year.
      Key updates from the AUA/ASRM male infertility guideline amendment
      September 23rd 2024

      Key updates from the AUA/ASRM male infertility guideline amendment

      Urology Times staff
      In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.
      Genomic tests may offer valuable prognostic insights, but clinical utility remains unclear
      January 22nd 2025

      Genomic tests may offer valuable prognostic insights, but clinical utility remains unclear

      Hannah Clarke
      "[The] full integration [of genomic classifier tests] into clinical practice requires additional research to better understand their cost-effectiveness, clinical utility, and impact on diverse populations," says Amir Alishahi Tabriz, MD, PhD, MPH.
      Dr. Murphy on increasing diversity in cancer clinical trials
      February 29th 2024

      Dr. Murphy on increasing diversity in cancer clinical trials

      Urology Times staff
      In this podcast episode, Adam B. Murphy, MD, MBA, MSCI, discusses the need to increase diversity in clinical trials, specifically focusing on studies in prostate cancer.
      3d rendered genetic illustration of human dna under microscope created with generative ai technology | Image Credit: © Picture Studio - stock.adobe.com
      December 24th 2024

      Quiz: CUA guidelines on specimen and timing considerations with genetic testing

      Patrick Campbell
      Test your knowledge of these often-overlooked but essential aspects of genetic and genomic testing.
      NCCN reaffirms Prolaris’ prognostic value in prostate cancer
      December 18th 2024

      NCCN reaffirms Prolaris’ prognostic value in prostate cancer

      Hannah Clarke
      The inclusion of the test is supported by more than 25 studies demonstrating its clinical utility, including 2 studies published earlier this year.
      © 2025 MJH Life Sciences

      All rights reserved.